Tag: patent delays

Despite FDA approval, generic drugs in the U.S. face average delays of 3.2 years before reaching patients due to patent litigation and complex regulatory tactics. Real-world examples from 2023-2025 show how brand companies use patent thickets to block competition, driving up costs and limiting access.